The successful sequencing of the novel coronavirus SARS-CoV-2 nucleic acid paved the way for exploration of omics systems science and integrative biology research approaches for combating this unprecedented planetary health challenge. Omics-scale studies on this viral infection are emerging rapidly and offer a tremendous potential to unravel the puzzles of the SARS-CoV-2 pathobiology, and ways forward for diagnostic and therapeutic innovation.
Get full access to this article
View all access options for this article.
References
1.
BojkovaD, KlannK, KochB, et al. (2020). Proteomics of SARS-CoV-2 infected host cells reveals therapy targets. Nature DOI: 10/1038/s41586-020-2332-7.
2.
EckhardtM, HultquistJF, KaakeRM, HüttenhainR, and KroganNJ. (2020). A systems approach to infectious disease. Nat Rev Genet DOI: 10.1038/s41576-020-0212-5.
3.
ForsterP, ForsterL, RenfrewC, and ForsterM. (2020). Phylogenetic network analysis of SARS-CoV-2 genomes. Proc Natl Acad Sci U S A, 117, 9241–9243.
4.
GordonDE, JangGM, BouhaddouM, et al. (2020). A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature DOI: 10.1038/s41586-020-2286-9.
5.
HoffmannM, Kleine-WeberH, SchroederS, et al. (2020). SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell, 181, 271–280.e8.
6.
LuR, ZhaoX, LiJ, et al. (2020). Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. Lancet, 395, 565–574.
7.
RayS, PatelSK, KumarV, DamaheJ, and SrivastavaS. (2014). Differential expression of serum/plasma proteins in various infectious diseases: Specific or nonspecific signatures. Proteomics Clin Appl, 8, 53–72.
8.
RayS, PatelSK, VenkateshA, et al. (2017). Quantitative proteomics analysis of Plasmodium vivax induced alterations in human serum during the acute and convalescent phases of infection. Sci Rep, 7, 4400.
9.
ShenB, YiX, SunY, et al. (2020). Proteomic and metabolomic characterization of COVID-19 patient sera. medRxiv DOI: 10.1101/2020.04.07.20054585.
10.
TayMZ, PohCM, RéniaL, MacAryPA, and NgLFP. (2020). The trinity of COVID-19: Immunity, inflammation and intervention. Nat Rev Immunol. DOI: 10.1038/s41577-020-0311-8.
11.
WangH, HouX, WuX, et al. (2020). SARS-CoV-2 proteome microarray for mapping COVID-19 antibody interactions at amino acid resolution. bioRxiv. DOI: 10.1101/2020.03.26.994756.
12.
WrappD, WangN, CorbettKS, et al. (2020). Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science, 367, 1260–1263.
13.
WuF, ZhaoS, YuB, et al. (2020). A new coronavirus associated with human respiratory disease in China. Nature, 579, 265–269.
14.
ZhouP, YangX-L, WangX-G, et al. (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 579, 270–273.
